Antiphospholipid syndrome: recent advances
نویسندگان
چکیده
منابع مشابه
Recent advances in understanding antiphospholipid syndrome
Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including th...
متن کاملRecent advances in understanding antiphospholipid syndrome [version 1; referees: 2 approved]
Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including th...
متن کاملRECENT ADVANCES Advances in haemolytic uraemic syndrome
The purpose of this review is to draw together recent advances in the pathogenesis of haemolytic uraemic syndrome (HUS) induced by verocytotoxin, including information from the successful Third International Symposium on Verocytotoxin Producing Escherichia coli, “VTEC’97”, in Baltimore.However, the highly publicised outbreaks of verocytotoxin producing Escherichia coli (VTEC) infection in Japan...
متن کاملRecent advances in Tourette syndrome.
PURPOSE OF REVIEW This review considers the recent literature pertaining to the neurobiology, genetics and treatment of Tourette syndrome. RECENT FINDINGS Over the last several years, both neuropathological and genetic findings have further focused attention on long-standing hypotheses regarding the role of the basal ganglia in causing tics and Tourette syndrome. Moreover, although the field ...
متن کاملRecent advances in hepatopulmonary syndrome.
Hepatopulmonary syndrome is defined as the clinical triad of advanced liver disease, arterial deoxygenation and intrapulmonary vascular dilatation. Its pathogenesis is not completely understood. Excessive pulmonary nitric oxide production seems to be one of the factors that contribute to the intrapulmonary vascular dilatation. Other mediators such as endothelin-1 and the heme oxygenase-1/carbon...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Rheumatology
سال: 2007
ISSN: 0973-3698
DOI: 10.1016/s0973-3698(10)60094-5